MedTrace Logo

CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients

NCT04049565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-02-05

No results posted yet for this study

Summary

Sepsis is a life threatening organ dysfunction caused by infection. Severe sepsis is expected to rise due to resistance to antibiotics. Inappropriate use of antibiotics in the ICU leads to adverse drug reaction and bacterial resistance. Using biomarkers for infection as PCT and CRP are useful in diagnosing infection and duration of therapy. CRP based protocol will be compared to PCT based protocol for reducing the length of stay and reduction of antibiotic use in critically ill patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Procalcitonin biomarker and CRP biomarker

collecting blood samples to measure serum CRP and Procalcitonin

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Abdelrahman Dr ElNaggar, Prof · study official is dead

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-02-01
Completion
2019-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04049565 on ClinicalTrials.gov